Lincoln Pharmaceuticals Ltd (LINCOLN) — Board Meeting | 5 September 2026

5 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

32nd AGM scheduled for September 30, 2026

💡 Investor Takeaway

Shareholders will vote on financial approvals and director reappointments at the upcoming AGM.

Lincoln Pharmaceuticals announced its 32nd Annual General Meeting will be held on September 30, 2026 at 11:00 a.m. IST via video conferencing. Shareholders will vote on adopting audited financial statements for FY2025-26, declaring an 18% dividend of ₹1.80 per share, and reappointing two directors. Special business includes ratifying cost auditor remuneration of [amount not verified] annually. The meeting notice was issued on August 13, 2026, with electronic delivery to shareholders and e-voting instructions provided.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LINCOLN ✨ Ask AI About This

About Lincoln Pharmaceuticals Ltd (LINCOLN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,174.34 CrP/E: 12.2ROE: 12.7%ROCE: 16.9%Div Yield: 0.31%

View full LINCOLN stock details →

📡 Get AI alerts when LINCOLN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LINCOLN — Free

💡 Ask AI about this filing

"What is the exact dividend payout ratio and record date?""How does director reappointment affect governance?""What are the e-voting participation rules for shareholders?"

Ask AI Free →

📊 More LINCOLN filings

🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the appointment of Pradeep Kumar Yadav as Senior General Manager-Q...
🔴 Announcement — 24 September 2026Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager- QA (Head QA...
Announcement — 23 September 2026Lincoln Pharmaceuticals has announced that its trading window will close on October 1, 2026, and rem...
🟡 Board Meeting — 29 August 2026Lincoln Pharmaceuticals announced a final dividend of 18% (₹1.80 per share) payable after approval a...
🟡 Board Meeting — 29 August 2026Lincoln Pharmaceuticals announced its 32nd Annual General Meeting on September 30, 2026, to approve ...

See all LINCOLN filings →

🔥 Also filed on 5 September 2026

MTARTECHMTAR Technologies LtdAnnual Report 544877Technocrats Plasma Systems LtdFinancial Results 519285Tarai Foods LtdFinancial Results 526827Spice Islands Industries LtdFinancial Results 539189Adhbhut Infrastructure LtdAnnual Report PARAGMILKParag Milk Foods LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LINCOLN files new disclosures

Track LINCOLN filings, board meetings, and corporate actions. Free email alerts at 5 PM.